CClinicalTrials.gg
CompletedNCT02370940Updated Feb 25, 2015

Regular Consumption of High Phytate Reduces Inhibitory Effect of Phytate on Iron Absorption

An interventional study of High phytate intake and Low phytate intake in Iron Bioavailability, sponsored by Iowa State University. Completed. Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-02-25.

Sponsored by Iowa State University · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

The purpose of this study is to investigate whether regular consumption of phytate dampens its negative effect on nonheme iron absorption.

Read the detailed description

Phytate is one of the main inhibitors of nonheme iron absorption. High phytate consumption is of concern in developing countries because of the high prevalence of iron and zinc deficiency in these countries. In this study, we investigated the effect of habitual consumption of a high phytate diet on the inhibitory effect of phytate on nonheme iron absorption. Thirty-two non-anemic female subjects with ferritin ≤ 30µg/L were randomized into two groups, after matching for ferritin concentration. Each group consumed either high or low phytate foods that were provided for 8 wk. Iron bioavailability from a high phytate test meal was measured using area under the curve (AUC) for serum iron at baseline and after the intervention.

02

Conditions studied

  • Iron Bioavailability

Keywords

  • Iron bioavailability
  • phytate
  • serum iron curve
  • hepcidin
  • iron status
03

In context

Lead sponsor

Iowa State University is the lead sponsor of 36 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Marginal iron status (Serum ferritin \<30ug/L)
  • BMI in the range 18.5-24.9kg/m2
  • Willing to modify diet to increase or decrease phytate intake
  • Willing to give multiple blood samples at beginning and end of study

Exclusion criteria

Exclusion Criteria:

  • Pregnant
  • Lactating
  • Smoker
  • Anemic (hemoglobin \<120 g/L)
  • Has gastro-intestinal disease/condition that can affect absorption
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    High Phytate Diet

    The high phytate diet group was required to consume a high phytate diet for 8 weeks. The high phytate foods were provided for subjects. They received whole grain ready-to-eat cereals, whole wheat pasta/spaghetti, tortillas, bagels, bread and dinner rolls, corn tortillas, brown rice, canned black beans, edamame and tofu, and were encouraged to consume generous amounts of nuts and other legume products high in phytate.

    Other: High phytate intake

  • Experimental
    Low Phytate Diet

    The low phytate diet group was required to consume a low phytate diet for 8 weeks. They received foods similar to those for the high phytate diet group but which were made from refined wheat and white rice, eggs and cheese, and were instructed to avoid high phytate foods.

    Other: Low phytate intake

Interventions

  • OtherHigh phytate intake
  • OtherLow phytate intake
06

What researchers measure

Primary outcomes

  1. Area under the curve for serum iron for assessing bioavailability

    Time frame: 8 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Armah SM, Boy E, Chen D, Candal P, Reddy MB. Regular Consumption of a High-Phytate Diet Reduces the Inhibitory Effect of Phytate on Nonheme-Iron Absorption in Women with Suboptimal Iron Stores. J Nutr. 2015 Aug;145(8):1735-9. doi: 10.3945/jn.114.209957. Epub 2015 Jun 3. PubMed 26041677 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 25, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02370940
Lead sponsor
Iowa State University
Collaborators
HarvestPlus
Responsible party
Dr. Manju B. Reddy (Professor, Iowa State University) — Principal investigator
First posted
Feb 25, 2015
Start date
Jan 2013
Primary completion
Apr 2013
Completion
Apr 2013
Last update
Feb 25, 2015

Study contacts

Manju B Reddy, PhD
principal investigator · Iowa State University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion